The plasma levels of adrenaline and noradrenaline have been measured in IO patients with myocardial infarction using a new double isotope dilution technique. Adrenaline and noradrenaline levels were measured on admission and at 12-hourly intervals for the next 5 days. There were significant correlations between raised noradrenaline and (i) raised systolic blood pressure, (2) the presence of pulmonary oedema, and (3) transfer of patients back to the general wards; and between raised adrenaline levels and (i) the presence ofpulmonary oedema, and (2) the presence of ventricular ectopics. The results suggest that emotional factors play a part in the increase in catecholamine levels in these patients and that adequate sedation may result in lower levels. One patient with cardiac arrest followed by complete heart block and cardiogenic shock had particularly high catecholamine levels, exceeding those observed in a case of phaeochromocytoma.
The study of the activity of the sympathetic nervous system and adrenal medulla in patients with myocardial infarction has been hampered by the difficulty of measuring, accurately, free adrenaline and noradrenaline levels in plasma. Until recently the methods for measuring these amines have relied on their properties of fluorescence under ultraviolet light. Workers who have used these techniques have often found accurate results hard to obtain at the low levels of catecholamines present in normal plasma (Crout, I959; Udenfriend, I959). In addition, these methods do not employ internal standardization for each individual sample and values for adrenaline must be derived from total catecholamine and noradrenaline values rather than being measured directly. There are, as has been shown recently by Carruthers et al. (I970) , several common dietary and therapeutic agents (including tea, coffee, ampicillin, vitamins, aminophylline, and lasix) which cause moderate or striking fluorescence in vitro when put through the same extraction and analysis stages as the plasma samples.
A new approach to this problem which has overcome these difficulties has been the application of the double isotope dilution technique by Engelman, Portnoy, and Loven- 
berg (I968). Recently this method has been
Received 25 February 197I. adapted (Siggers, Salter, and Toseland, I970) to allow differential measurement of adrenaline and noradrenaline in plasma as well as total catecholamine levels.
Increased levels of catecholamines in the urine after myocardial infarction have been reported by many authors (Forssman, Hansson, and Blood samples (20 ml) were taken by venepuncture into a siliconized syringe and transferred to a tube containing sodium citrate and ascorbic acid. The tube was kept in ice and spun down within IO minutes in a refrigerated centrifuge to separate the plasma. Small quantities of tritiumlabelled adrenaline and tritium-labelled noradrenaline were added to each sample as an internal standard. Plasma samples (io ml) were passed through a cation exchange column and then incubated with the enzyme catechol-ortho-methyl transferase together with a 14C-labelled methyl donor (adenosyl methionine) to convert them to the 14C-methyl derivatives: 14C metadrenaline and 14C normetadrenaline. The enzyme reaction was stopped and 20 ,g each of unlabelled metadrenaline and normetadrenaline were added as carriers and as markers for the subsequent electrophoresis. The methylcatecholamines were extracted in ether (Anton and Sayre, I966) and subjected to electrophoresis at 500 volts on a thin layer of cellulose to separate the metadrenaline from the normetadrenaline. These substances were dyed with a p-nitraniline spray. Each spot was transferred into a vial together with toluene scintillant and thixotrophic gel. The vials were placed in a scintillation counterandcounted fortritium and 14C. The percentage recovery of each individual sample was known from the tritium count, and, by the ratio of 14C to tritium, the levels of noradrenaline and adrenaline in the original sample were calculated.
Recoveries usually ranged from IO to go per cent but occasionally samples gave a very poor recovery and could not be used for calculations. The plasma catecholamine levels in the first patient measured were not differentiated into adrenaline and noradrenaline.
Patients
Ten patients, admitted with acute myocardial infarction, were selected randomly for this study. Nine patients were male and one was female. The ages ranged from 47 to 68 years, with a mean age of 59 years. The diagnosis of acute myocardial infarction was made on the usual electrocardiographic criteria together with an increase in the serum levels of myocardial enzymes in 9 patients. In one patient, however, the electrocardiogram showed changes of an old posterior infarct, and the enzyme levels did not rise. However, the clinical history and course were highly suggestive of a recent myocardial infarction.
Results
The mean noradrenaline and adrenaline levels for the nine patients are shown in Fig. i and 2 . The upper limit of the normal levels based on a series of blood samples taken from IO normal volunteers was found to be o-6o ,ug/l. for noradrenaline and 0o25 ,ug/l. for adrenaline. On admission the levels were above normal but by the final sample on the fifth day they had returned to normal. There was a rise in both adrenaline and noradrenaline on the fourth day.
There was a significant linear correlation between raised noradrenaline levels and systolic blood pressure (correlation coefficient 0-323 P <0-02) but not between adrenaline and systolic blood pressure. No significant linear correlation was found between either adrenaline or noradrenaline and pulse rate. One patient who developed complete heart block had very high levels of catecholamines, particularly when the ventricular rate was not being maintained with a pacemaker (Fig. 3) . On the other hand, a patient who developed sinus bradycardia was found to have normal levels initially, though one other patient with normal levels on admission did not have a slow heart rate. Patients who developed ventricular ectopics had significantly higher peak levels of adrenaline (P < 0-02), but not noradrenaline, than those with no observed ventricular ectopics. However, when all levels of both noradrenaline and adrenaline were analysed they were not significantly higher in the presence of ventricular ectopics (Table i) .
The presence of pulmonary oedema was associated with significantly higher levels of both adrenaline (P < o oos) and noradrenaline (P < o0o5). However, peak values of adrenal- ine and noradrenaline in patients with pulmonary oedema were not significantly different from those without, though it must be appreciated the numbers were small for statistical analysis (Table i) .
The first blood sample taken after return to the general ward from the intensive care unit showed a significantly higher mean level of noradrenaline (P< oo5) than the sample taken immediately before transfer. Mean adrenaline levels were also higher but not (Fig. 4 and Table i ). Plasma noradrenaline and adrenaline levels in a patient with a phaeochromocytoma are shown ( Table 2) for comparison with the levels of plasma catecholamines after myocardial infarction, and it can be seen that in one patient with acute myocardial infarction (Fig. 3) the levels of catecholamines even exceeded these values.
Discussion
The new isotope dilution method for differential estimation of plasma adrenaline and noradrenaline gives a specific separation of the two amines and an accurate recovery value for each sample. There is no interference from fluorescent substances in the plasma. A recent study (Carruthers et al., 1970) reported that venepuncture did not cause a significant increase in noradrenaline levels, but suggested there was a significant increase in adrenaline levels. The method used for that study, however, relies on derived values for adrenaline and not on direct measurements making the values 'much less dependable' (Carruthers et Vendsalu (I960) showed that catecholamine levels increased when his subjects changed to the head-up tilt position from the recumbent position, and it is possible that withdrawal of sedation from our patients tended to encourage them to adopt a sitting position in bed instead of a recumbent one. This work (Vendsalu, i960), however, was carried out Io years ago by an earlier fluorescent method and needs re-examination.
The relation between blood pressure and noradrenaline level is complex. Valori et al. (I967) found no clear correlation, since patients with normal arterial pressures had either normal or raised urinary catecholamines; patients with low arterial pressures also had variable catecholamine levels but those with more severe degrees of heart failure had the higher catecholamine levels. The patient with episodes of hypotension and bradycardia related to complete heart block had very high plasma catecholamine levels related to these episodes, while at other times, when blood pressure and pulse rate were supported at normal levels by an endocardial pacemaker, the catecholamine levels were not as high though they were still raised above normal (Fig. 3 ). In the other 9 patients, none of whom was hypotensive, there was a correlation between raised systolic blood pressure and increased noradrenaline levels. ) found high levels of urinary catecholamines in pulmonary oedema and increasing levels with increasing severity of heart failure. We found significantly higher noradrenaline (P < o0o5) and adrenaline (P < o-oo5) levels with pulmonary oedema. However, mean peak levels of both adrenaline and noradrenaline in patients with pulmonary oedema were little different from those in patients without pulmonary oedema, but it must be remembered that the number of patients studied was not large. The patient illustrated in Fig. 3 had the features of severe congestive heart failure on two occasions, when in complete heart block unsupported by a pacemaker, and the plasma catecholamine levels on these occasions were the highest recorded in the series. 
